Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The antioxidant redox network is a sophisticated, multi-layered system of enzymes and small molecules that maintains cellular redox homeostasis by regulating the production and elimination of reactive oxygen species (ROS) and reactive nitrogen species (RNS) [1]. This network includes primary antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), as well as non-enzymatic components like glutathione (GSH), thioredoxin, and dietary antioxidants like vitamins C and E [2]. The network is centrally regulated by the Nrf2 (Nuclear factor erythroid 2-related factor 2) signaling pathway, which orchestrates the expression of numerous cytoprotective genes in response to oxidative stress [3]. Dysregulation of this network is a hallmark of many chronic conditions, including cancer, neurodegenerative diseases (like Parkinson's and Alzheimer's), and cardiovascular disorders, where excessive ROS lead to macromolecular damage [4]. Therapeutic strategies often focus on specific nodes within the network, such as Nrf2 activators (e.g., dimethyl fumarate) or glutathione precursors (e.g., N-acetylcysteine), to bolster the cell's natural defenses [5]. However, targeting the network is challenging because ROS also function as essential signaling molecules for cell growth and immune responses; thus, excessive antioxidant intervention can lead to "reductive stress" and unintended toxicity [6]. [1] Sies, H., et al. (2017). Nature Reviews Molecular Cell Biology. [2] Halliwell, B., & Gutteridge, J. M. (2015). Free Radicals in Biology and Medicine. [3] Ma, Q. (2013). Annual Review of Pharmacology and Toxicology. [4] Forman, H. J., & Zhang, H. (2021). Nature Reviews Drug Discovery. [5] Liby, K. T., & Sporn, M. B. (2012). Nature Reviews Cancer. [6] Ursini, F., et al. (2016). Redox Biology.
Activation of the Nrf2-Keap1 pathway to induce cytoprotective genes, direct scavenging of reactive oxygen species (ROS), and replenishment of endogenous antioxidant pools such as glutathione.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antioxidant redox network.